About Editorial team of BIPNs

Main team of content of bipns.com. Any type of content should be approved by us.
23 12, 2025

XRP Trades Below $2 as ETF Buying Fails to Lift Price

By |2025-12-23T02:51:48+02:00December 23, 2025|Crypto News, News|0 Comments

  • XRP stays below $2 despite 25 straight days of ETF inflows.
  • Weekly ETF inflows fell to $82M, the lowest since the November launch.
  • ETF buying removes supply gradually but does not prevent short-term volatility.

XRP price has struggled to regain momentum, remaining below the $2 mark even as U.S. spot ETFs tied to the token continue to attract fresh capital. The disconnect has left investors asking a simple question: If money is flowing in, why isn’t the price moving?

The answer appears to lie beyond XRP itself.

ETF Demand Is Real, but Slowing

Data from SoSoValue shows XRP spot ETFs recorded $82.04 million in net inflows during the December 15–19 trading week. While still positive, it was the lowest weekly inflow since the ETFs launched in November.

So far, the U.S. market has approved five XRP spot ETFs, compared with 11 Bitcoin spot ETFs, showing the d…

Read The Full Article XRP Trades Below $2 as ETF Buying Fails to Lift Price On Coin Edition.

Source link

23 12, 2025

Henry Hub Slides Toward $4 as Warm Forecasts Cap Rally; Europe Tracks Storage; Australia Tightens Domestic Supply Rules

By |2025-12-23T01:41:37+02:00December 23, 2025|Forex News, News|0 Comments


December 22, 2025 — Natural gas markets are starting the holiday-shortened week with a familiar winter tug-of-war: early-season cold boosted prices and withdrawals, but a shift toward milder forecasts is now cooling bullish momentum even as LNG export demand remains elevated.

In the U.S., front-month NYMEX natural gas futures slipped close to 2% in morning trade as forecasters leaned warmer into early January and Lower 48 production continued to surprise to the upside. Overseas, European gas prices edged lower in thin pre-holiday trading as steady supply from Norway and LNG flows helped offset expectations of stronger heating demand. Meanwhile, a wave of policy and geopolitics headlines—from Australia’s new gas reservation framework to fresh Russia-to-China pipeline and sanctioned LNG shipping developments—kept global traders focused on 2026–2027 contract risk and supply security.


Natural gas price today: U.S. futures ease as warmth returns to the forecast

U.S. natural gas futures fell by roughly 1.9% in the morning session, with the January contract around $3.901 per MMBtu at 09:40 a.m. ET, pressured by both higher production and forecasts that point to warmer-than-normal temperatures into early January—conditions that typically reduce heating demand. [1]

This pullback follows a sharp early-December run-up that briefly pushed Henry Hub pricing to multi-year highs. The American Gas Association’s latest market indicators describe a clear shift in sentiment: after an early cold snap, demand has eased and futures have been “retreating,” with weather remaining the dominant driver of daily volatility. [2]

Key U.S. price context (December swing):

  • The AGA notes the January prompt-month contract settled at $3.98/MMBtu on Dec. 19, down materially from early-month levels and well below the early-December peak (AGA cites a $5.29/MMBtu three-year high on Dec. 5). [3]
  • Intraday trade on Dec. 22 briefly pushed toward ~$4.14/MMBtu in the AGA’s “time of writing” snapshot, underscoring how quickly prices can whipsaw on forecast changes. [4]

Weather forecast: the market is trading January warmth, not last week’s cold

The near-term narrative has shifted from “how cold did it get?” to “how warm will it be next?” Meteorologists cited in today’s market reporting expect the U.S. to remain mostly warmer than normal through early January, which would limit space-heating demand relative to seasonal norms. [5]

The AGA likewise points to holiday-period moderation, citing NOAA Climate Prediction Center outlooks that tilt above-normal across much of the country into the first week of the new year, with some regional exceptions. [6]

What matters for traders is not just temperature direction, but the speed and confidence of model changes. A single forecast shift can reprice the entire front of the curve, especially when liquidity thins around Christmas and New Year’s.


Production: record output is the bear case that won’t go away

Even in winter, it’s hard for prices to sustain a rally when supply keeps setting new highs.

Financial firm LSEG data referenced in today’s reporting shows average Lower 48 output climbing to a record 109.9 Bcf/d so far in December, eclipsing November’s monthly record. [7]

The AGA similarly notes that after hitting an all-time daily high late last month, production dipped briefly and then rebounded; as of Dec. 22, output remained meaningfully higher than the same period last year (AGA cites +4.8% year over year). [8]

Why this matters for “natural gas price today” searches:
When supply is printing records, bullish weather needs to be consistently colder than normal—not just briefly cold—to keep prices elevated. Otherwise, the market tends to sell rallies and reward storage comfort.


Demand and storage: withdrawals rose early, but inventories still look “okay”

Demand cooled week over week, but it’s not collapsing. The AGA reports total demand (including exports) for the week ending Dec. 22 fell 11.5% week over week while still running slightly above last year’s level for the comparable week. [9]

On the storage side, the latest widely cited U.S. weekly pull was sizable: the EIA reported a 167 Bcf withdrawal for the week ending Dec. 12, leaving working gas inventories at 3,579 Bcf. The AGA states stocks were about 0.9% above the five-year average at that point, though below year-ago levels. [10]

Bottom line: the early-winter drawdown was real, but strong production and still-comfortable inventories are limiting the urgency premium—especially when warmer forecasts appear.


LNG exports: record feedgas is still the structural bullish pillar

If there’s a consistent floor under U.S. gas demand, it’s LNG.

Today’s reporting puts average feedgas flows to the eight large U.S. LNG export plants at 18.5 Bcf/d so far this month, up from a prior monthly record in November. [11]

AGA’s December 22 indicators add more color:

  • Feedgas deliveries were materially higher year over year (AGA cites +32.6% versus the first three weeks of December 2024). [12]
  • U.S. LNG shipping set a weekly record earlier this month, with 40 vessels departing in the week ending Dec. 10 and a combined carrying capacity of 151 Bcf (as cited by AGA from EIA shipping data). [13]

In other words: even if residential/commercial heating softens on warmth, export pull can keep the overall balance tighter than it looks from weather alone.


Forecast: what EIA expects for winter prices, withdrawals, and 2026 supply

For readers looking beyond today’s tick-by-tick move, the EIA’s Short-Term Energy Outlook provides the clearest baseline forecast widely used in the market:

  • EIA expects the Henry Hub spot price to average about $4.30/MMBtu this winter heating season (Nov–Mar), citing early-December cold and stronger space-heating demand than previously assumed. [14]
  • Based on NOAA data, EIA assumes December will have more heating degree days than the 10-year average, boosting residential and commercial consumption and reducing storage. [15]
  • EIA forecasts December withdrawals totaling ~580 Bcf and expects end-of-winter inventories around 2,000 Bcf (still above the five-year average in their outlook). [16]
  • For 2026, EIA projects U.S. dry gas production averaging about 109 Bcf/d, with higher gas-to-oil ratios in the Permian contributing to supply growth. [17]

This is the macro framework traders are testing daily against real-time weather and production data.


Europe natural gas today: TTF edges lower as Norway and LNG supply offset cold risk

European prices opened the week slightly softer, with trading described as narrow and holiday-thinned.

Reuters reporting cited Dutch February TTF down modestly to about €27.70/MWh in morning trade, while UK day-ahead prices also eased. Market participants pointed to steady Norwegian pipeline supply and LNG availability offsetting the colder-demand outlook. [18]

Storage remains the key European risk variable. Reuters also cited Gas Infrastructure Europe data putting EU storage around 67.24% full, and noted that lower inventory levels could encourage additional LNG procurement into January and February if winter demand strengthens. [19]

European takeaway: the region is not “out of gas,” but it is more sensitive to cold snaps and supply disruptions than it would be with storage closer to last year’s levels.


Australia gas policy: mandatory domestic reservation set to reshape 2027 contracts

One of the biggest policy headlines of Dec. 22 comes from Australia, where the government unveiled a domestic gas reservation framework aimed at preventing future east-coast shortages and smoothing price spikes.

Reuters reports the plan would require LNG exporters on Australia’s east coast to allocate 15% to 25% of output for domestic use starting in 2027, with the mechanism designed around new contracts rather than existing long-term commitments. [20]

Australian media reporting frames the move as a “historic” shift for the east coast and suggests reserved volumes could reach hundreds of petajoules annually, with the policy intended to slightly oversupply the domestic market and put downward pressure on prices. [21]

Why this matters globally: Australia is a top-tier LNG exporter into Asia, and any policy that changes how incremental supply is marketed can ripple into longer-dated LNG pricing, portfolio contracting strategy, and buyer diversification plans.


Russia and global supply: China pipeline volumes rise, sanctioned LNG cargoes move

Two Russia-linked gas developments reported on Dec. 22 underscore the market’s geopolitical undercurrent:

1) Russia-to-China pipeline gas is rising fast—but it doesn’t replace Europe

A Reuters report says Russian pipeline exports to China via Power of Siberia are expected to reach ~38.6–38.7 bcm in 2025, up from 31 bcm in 2024, and roughly at/above the pipeline’s planned annual capacity. The report also notes discussions on additional projects (including Power of Siberia 2), with pricing still a major hurdle. [22]

2) A tanker loaded LNG from a sanctioned Russian project

Reuters also reported that the LNG tanker Kunpeng loaded a cargo from Russia’s Portovaya LNG plant—despite Western sanctions—based on ship-tracking data. The vessel arrived Dec. 18 and departed with a cargo on Dec. 21, according to the report. [23]

For the market, these stories are less about today’s Henry Hub tick and more about future trade flows, enforcement risk, and how quickly supply can be rerouted when traditional buyers reduce purchases.


Natural gas outlook: 7 things traders are watching next

With Christmas approaching and liquidity thinning, the next moves could be driven by a small number of catalysts:

  1. U.S. temperature model volatility into early January (warmth vs. renewed cold shots). [24]
  2. Lower 48 production—whether record output persists or freeze-offs/maintenance tighten supply. [25]
  3. LNG feedgas and shipping cadence—any new daily/weekly export records, or outages that cut flows. [26]
  4. Storage trajectory—whether withdrawals meaningfully slow if warmth dominates late December. [27]
  5. European storage and wind/weather patterns—which affect both gas-fired generation and LNG bidding intensity. [28]
  6. Australia’s reservation design details—especially how “15%–25%” is applied across projects and contract types. [29]
  7. Russia-related trade and sanctions enforcement—pipeline expansion negotiations and sanctioned LNG cargo movements. [30]

References

1. www.bairdmaritime.com, 2. www.aga.org, 3. www.aga.org, 4. www.aga.org, 5. www.bairdmaritime.com, 6. www.aga.org, 7. www.bairdmaritime.com, 8. www.aga.org, 9. www.aga.org, 10. www.aga.org, 11. www.bairdmaritime.com, 12. www.aga.org, 13. www.aga.org, 14. www.eia.gov, 15. www.eia.gov, 16. www.eia.gov, 17. www.eia.gov, 18. www.tradingview.com, 19. www.tradingview.com, 20. www.reuters.com, 21. www.theguardian.com, 22. www.reuters.com, 23. www.reuters.com, 24. www.bairdmaritime.com, 25. www.bairdmaritime.com, 26. www.bairdmaritime.com, 27. www.aga.org, 28. www.tradingview.com, 29. www.reuters.com, 30. www.reuters.com



Source link

23 12, 2025

This Weight-Loss Fave Fiber Supplement Can Help With Brain Health

By |2025-12-23T00:56:34+02:00December 23, 2025|Dietary Supplements News, News|0 Comments


Fiber has a great reputation for helping people keep their bowel movements regular, and during the Ozempic boom, it’s become an even more buzzy nutrient thanks to its ability to support weight loss and improve satiety (like GLP-1s). But this special carbohydrate can actually do so much more than just keep you on a schedule and promote good gut health. New research suggests fiber could actually support good brain health, too.

Right now, only about 5 percent of Americans get enough fiber in their diet, so it might be time to rethink how much fiber you’re getting on a daily basis. One way is by loading up on psyllium husk, which has been dubbed “nature’s Ozempic.”

Here’s why you may want to consider adding more fiber—and psyllium husk—to your day, plus how to actually go about it, according to experts.

Meet the experts: Molly Rapozo, RDN, is a senior nutrition and health educator at Pacific Neuroscience Institute at Providence Saint John’s Health Center in Santa Monica, CA; Jessica Cording, RD, CDN, is the author of The Little Book of Game-Changers; Clifford Segil, DO, a neurologist at Providence Saint John’s Health Center in Santa Monica, CA.

How does fiber boost brain health?

Recent research shows loading up on fiber can do your brain health a solid.

One randomized controlled trial published in Nature Communications last year split 36 pairs of twins into two groups: One took a placebo and the other took a daily fiber supplement for 12 weeks. The researchers discovered that people in the fiber supplement group did better on brain function assessment tests and showed better reaction times and processing speeds than those in the placebo group.

A slightly older rat study also found that psyllium husk in particular reduced white matter damage in the brain, which is a symptom associated with dementia.

The link between getting plenty of fiber and good brain health is likely tied to the gut-brain axis, a network of connections between your gut and your brain, says Clifford Segil, DO, a neurologist at Providence Saint John’s Health Center in Santa Monica, CA.

“I often see patients with gastrointestinal complaints like abdominal pain also have neurological complaints like headaches,” he says. “Fiber is important for gastrointestinal health as it helps our bodies excrete out waste and aids in flushing our system.”

Dr. Segil says he’s seen patients have fewer headaches when they’re able to take care of their gut health. “A happy gut with fiber may cause a happy brain by helping our bodies clean themselves out and balance things better,” he says.

Is psyllium husk a good source of fiber?

Let’s back up a sec: Psyllium husk is a soluble plant fiber, which means it pulls in water and creates a gel-like substance in your gut, says Jessica Cording, RD, CDN, author of The Little Book of Game-Changers. “It helps with building stool bulk and can help you to feel full,” she explains.

And yes, Cording says that psyllium husk is a great tool for upping your fiber intake. “It can support heart health, digestive regularity, and weight management,” she says.

A diet high in fiber—including psyllium husk—”is healthy for diabetes, hypertension, and for both cardiovascular and cerebrovascular health,” Dr. Segil says.

What other sources of fiber can I add to my diet?

Eating a diet rich in plants is the best way to meet your fiber needs, according to Molly Rapozo, RDN, senior nutrition and health educator at Pacific Neuroscience Institute at Providence Saint John’s Health Center in Santa Monica, CA. And those same fiber sources tend to be nutrient rich, so it’s a win-win.

Here are some of the best sources of fiber, according to the Dietary Guidelines for Americans:

  • Bran cereal
  • Lima beans
  • Artichokes
  • Lentils
  • Guava
  • Broccoli
  • Raspberries
  • Popcorn
  • Cooked bulgar
  • Pumpkin seeds

How much fiber should I be consuming?

Fiber recommendations vary slightly by age and gender, but it’s generally suggested that you aim to consume 28 grams a day.

If you’re taking fiber supplements for the first time, start small (think ½ teaspoon in an 8-ounce glass of water once a day) before ramping up, according to Mount Sinai. You can gradually up your dosage as time goes on.

What are some other good fiber supplements?

While psyllium husk is a common fiber supplement, Cording says you can also get in fiber by adding chia seeds to your diet. “You can also look for products that use chicory root and inulin as the fiber source,” she says.

Again, if you’re able to get fiber in your diet from your diet alone, that’s great. But if you need a boost, adding psyllium husk to your day isn’t a bad idea—for your body or your mind.

NOW Psyllium Husk Powder

Now 23% Off

Credit: NOW Supplements

“This can work to relieve both constipation by increasing stool bulk and diarrhea by helping to absorb water and slow down stool passage in the colon,” dietitian May Zhu, RD, the founder of Nutrition Happens, previously told WH. It’s also versatile and can be added to beverages or soft foods.

On Sale

3-in-1 Psyllium Husk Fiber Supplement

Metamucil 3-in-1 Psyllium Husk Fiber Supplement
Credit: Metamucil

This capsule is designed to help you maintain healthy blood sugar levels, lower cholesterol, promote digestion and gut health, and support regular bowel movements. Another perk? Metamucil is a top-recommended brand, according to our experts, so you can trust the quality and purity of your supps.

GOGO Fiber Gummies

O Positiv GOGO Fiber Gummies

“These are orange sorbet-flavored and get their fiber from chicory root providing three grams of fiber per two gummies,” Amy Gorin, RDN, an inclusive plant-based dietitian previously told WH. Taking them will keep you regular and support good gut bacteria.

FiberMend Prebiotic Powder

Thorne FiberMend Prebiotic Powder
Credit: Thorne

This plant-based, water-soluble fiber helps you deal with constipation and aids digestion overall. It’s sugar-free, mixes easily with your favorite bev, and it’s rich in antioxidants.

Headshot of Korin Miller

Korin Miller is a freelance writer specializing in general wellness, sexual health and relationships, and lifestyle trends, with work appearing in Men’s Health, Women’s Health, Self, Glamour, and more. She has a master’s degree from American University, lives by the beach, and hopes to own a teacup pig and taco truck one day.



Source link

23 12, 2025

ADA Price Outlook Weakens Despite Stable Derivatives Activity

By |2025-12-23T00:50:37+02:00December 23, 2025|Crypto News, News|0 Comments

  • ADA stays below all key EMAs, keeping the short-term structure bearish and fragile.
  • Derivatives show lower leverage and steady open interest, signaling consolidation.
  • Weak spot flows and protocol caution keep buyers sidelined near critical support.

Cardano price action continues to reflect strain as ADA trades within a fragile short-term structure. The 4-hour chart shows persistent weakness, with sellers maintaining control despite brief recovery attempts. 

ADA Price Structure Remains Under Pressure

ADA remains locked in a short-term downtrend on the 4-hour timeframe. Price continues to trade below key moving averages, including the 20, 50, 100, and 200 EMAs. Consequently, bearish momentum remains intact across lower timeframes.

Recent price action shows a mild rebound from the $0.346 to $0.350 zone. However, buyers failed to sustain momentum, and lower highs…

Read The Full Article Cardano Price Prediction: ADA Price Outlook Weakens Despite Stable Derivatives Activity On Coin Edition.

Source link

22 12, 2025

XAG/USD Near Record High as Fed-Cut Bets and Geopolitics Fuel a Historic Rally

By |2025-12-22T23:40:38+02:00December 22, 2025|Forex News, News|0 Comments


Silver is extending one of the most dramatic bull runs in modern commodities history, with prices hovering near record territory on Monday, December 22, 2025. Around 1:38 p.m. ET, spot silver (XAG/USD) was trading roughly in the high-$68s per ounce, after pushing to fresh all-time highs earlier in the session. One widely followed retail spot quote showed $68.89/oz at 1:20 p.m. ET, up about 2.1% on the day. [1]

The bigger headline: silver has repeatedly printed new records in December and is now riding a powerful mix of rate-cut expectations, a softer U.S. dollar, safe-haven demand tied to geopolitical risk, and a still-tight physical market. Reuters reported spot silver touched a new all-time peak around $69.44/oz on Monday before easing back. [2]

Below is what’s moving the silver price today, how analysts are framing the rally, and what the latest forecasts and technical levels suggest for the days ahead.


Silver price today: where XAG/USD is trading and what the market just did

Silver’s intraday action has been volatile but directionally bullish:

  • Spot silver near 1:38 p.m. ET: fluctuating in the high-$68s, depending on the data provider and whether you’re viewing spot or CFD-style pricing. Retail spot pricing showed $68.89 at 1:20 p.m. ET. [3]
  • Earlier record high: Reuters cited a fresh all-time peak near $69.44/oz. [4]
  • Intraday range: one major pricing page showed a day’s range roughly $67.17 to $69.45, underscoring how fast price discovery is happening at these levels. [5]

Silver’s 2025 move is also historically large. Reuters put silver’s year-to-date gain at roughly ~139%, dramatically outpacing gold on a percentage basis. [6]


Why silver is surging: the three drivers dominating December 22

1) Rate-cut expectations are back in control

The macro backdrop remains the core engine. Multiple reports describe investors positioning for looser U.S. monetary policy in 2026, a setup that tends to support non-yielding assets like precious metals.

Reuters said expectations of easier policy and a weaker dollar have been central to the late-year precious metals surge, with traders reacting to recent U.S. inflation and labor data that reinforced rate-cut bets. [7]

Business Insider similarly tied the record push in gold and silver to renewed market confidence that rates will trend lower into 2026, increasing the appeal of hard assets versus cash and bonds. [8]

2) Geopolitical risk is amplifying safe-haven demand

Today’s rally isn’t only macro—it’s also risk hedging. Reuters highlighted rising safe-haven flows as U.S.-Venezuela tensions escalated following President Donald Trump’s announcement of a “blockade” targeting sanctioned oil tankers moving in and out of Venezuela. [9]

On top of that, FXStreet framed silver’s jump as part of a broader flight to safety amid renewed tension in the Middle East, noting Israel–Iran headlines as a catalyst during the Asian session. [10]

3) Silver’s “dual identity” is attracting both hedgers and growth traders

Silver is behaving like a hybrid: part safe haven, part industrial metal. Reuters has repeatedly emphasized the market’s focus on a persistent supply-demand deficit, while also pointing to investment flows. [11]

Business Insider added another layer: silver (along with copper) is being treated as an “AI and electrification” metal because of its role in data infrastructure and electrification, at a time when supply pressures remain a theme. [12]


The “record rally” narrative: what today’s reporting is telling investors

A major reason silver’s move is commanding attention is that it’s arriving late in the year—when markets often get thin and profit-taking typically increases.

Reuters quoted analysts observing that investors have not treated the year-end period as a time to step away from the trade, with strong demand pushing prices to records anyway. [13]

That said, several analysts are also warning that silver’s volatility cuts both ways. Reuters has flagged the risk of steep corrections even in a structurally bullish market, simply because silver historically moves faster than gold in both directions. [14]


Silver vs gold: the gold–silver ratio is flashing “silver strength”

A key metric confirming silver’s outperformance is the gold–silver ratio (how many ounces of silver it takes to buy one ounce of gold).

Reuters reported the ratio has narrowed to roughly 64, down sharply from about 105 in April, reflecting how aggressively silver has caught up—and, recently, outpaced. [15]
FXStreet also pegged the ratio near 64.06 on Monday. [16]

In plain terms: silver isn’t just rising because gold is rising—silver is rising faster.


Forecasts and outlook: what analysts are projecting next

Forecasts for silver are widening—bulls point to structural deficits and macro tailwinds, while cautious houses warn that the pace of gains looks unsustainable in a straight line.

A notable 2026 forecast: Macquarie’s average price view

In Reuters’ Dec. 22 coverage, Macquarie strategists said drivers behind silver’s recent highs include the persistent deficit and stronger import demand in India during the festive period—and they expect silver to average $57 per ounce in 2026. [17]

That forecast matters because it implies meaningful downside from today’s near-$69–$70 neighborhood, even while acknowledging supportive fundamentals.

The “if gold cools, silver cools” camp

CBS News cited Capital Economics projecting gold could fall to $3,500 by the end of next year, arguing that a cooling in gold’s speculative boom would likely spill into silver as well. [18]

The “bigger precious-metals cycle” camp

CBS also quoted Global X ETFs’ Trevor Yates describing the latest leg of the rally as being driven by a 2026 outlook featuring lower rates and a potentially softer dollar, adding that the firm remains constructive on both gold and silver (while acknowledging the path won’t be smooth). [19]

Bottom line on forecasts today: even among bullish narratives, there’s a growing emphasis on volatility and the risk that silver can overshoot before it mean-reverts.


Technical analysis: key levels traders are watching on Dec. 22

Technical analysts are largely aligned that the trend remains bullish—but momentum indicators are stretched.

FXStreet’s technical forecast described silver as extending a well-established uptrend and printing fresh records around the $69.45 area during the Asian session. It also highlighted that last week’s breakout through $66.40–$66.50 was an important trigger level, while warning that overbought RSI readings argue for caution when chasing breakouts. [20]

A separate market write-up echoed that bullish bias, pointing to silver holding above its 100-hour moving average and showing strengthening momentum signals. [21]

What this means in practice:

  • Bulls are focused on whether silver can hold above former breakout zones on pullbacks.
  • Bears (or cautious longs) are watching for signs of exhaustion as overbought conditions persist.

The India angle: local silver prices also hit records

The rally is not just a U.S. dollar story. In India, Times of India reported silver futures surged to a record ₹2,14,534 per kilogram on MCX as the global rally spilled over into domestic markets. [22]

This matters because India can be a major swing factor in physical demand—especially during periods of strong seasonal buying.


What to watch next: the catalysts that could move silver from here

Silver is now trading in a zone where headlines can move price quickly, because positioning is heavy and liquidity can be thinner near year-end. The market’s next moves are likely to hinge on:

  • Fed path signals for 2026: any shift in how quickly markets expect rate cuts can reprice precious metals. [23]
  • U.S. dollar direction: Reuters noted the dollar’s weakness has been part of the broader support for bullion. [24]
  • Geopolitical developments: today’s rally has been tightly linked to elevated geopolitical tension, which tends to boost safe-haven demand. [25]
  • Physical market tightness and investment flows: persistent deficit narratives and investment buying have been central to silver’s outperformance in 2025. [26]

Takeaway: silver is still bullish—but the market is pricing in turbulence

As of early afternoon on December 22, 2025, silver remains near record levels, supported by a powerful combination of macro tailwinds, geopolitical risk hedging, and tightness themes in the physical market. [27]

But today’s coverage also makes one point increasingly clear: the higher silver goes, the more the market is bracing for sharp swings—especially with technical signals stretched and forecasts for 2026 diverging widely. [28]

References

1. www.bullion.com, 2. www.reuters.com, 3. www.bullion.com, 4. www.reuters.com, 5. www.investing.com, 6. www.reuters.com, 7. www.reuters.com, 8. www.businessinsider.com, 9. www.reuters.com, 10. www.fxstreet.com, 11. www.reuters.com, 12. www.businessinsider.com, 13. www.reuters.com, 14. www.reuters.com, 15. www.reuters.com, 16. www.fxstreet.com, 17. www.reuters.com, 18. www.cbsnews.com, 19. www.cbsnews.com, 20. www.fxstreet.com, 21. uk.investing.com, 22. timesofindia.indiatimes.com, 23. www.reuters.com, 24. www.reuters.com, 25. www.reuters.com, 26. www.reuters.com, 27. www.reuters.com, 28. www.fxstreet.com



Source link

22 12, 2025

key facts, research studies, and advice for journalists

By |2025-12-22T22:55:43+02:00December 22, 2025|Dietary Supplements News, News|0 Comments


by Naseem S. Miller, The Journalist’s Resource
December 22, 2025

Whether it’s on TV commercials or posts by social media influencers, dietary supplements are marketed as a daily need to maintain optimal health, or as a quick fix for a range of ailments and conditions, from hair loss to weight management.

And although dietary supplements like vitamins can benefit some people, including older adults, pregnant people and individuals at risk of nutrient deficiencies, there’s little evidence that they benefit the average healthy person. Some supplements may contain contaminants that are harmful, and some may interact with prescription or over-the-counter medications.

However, these products continue to grow in popularity, including a surge during the COVID-19 pandemic.

A 2023 study published in Nutrients finds that the COVID-19 pandemic led to a significant surge in the use of dietary supplements globally, mainly for their perceived immune-boosting effects, even though there’s very little known about how effective these products are against COVID-19.

One reason for the persisting popularity of supplements in the U.S. is that it’s “just ingrained into the American society that we should be able to go and treat ourselves when we have health issues, and not have to necessarily get the advice or prescriptions from doctors,” says Dr. Pieter Cohen, an associate professor at Harvard Medical School and a national expert on dietary supplements.

Because the Food and Drug Administration does not approve dietary supplements before they’re marketed, there is no complete list of supplements sold in the U.S. There are between 80,000 to 100,000 different supplements available to consumers in the U.S., according to an estimate by the agency.

The future of supplement regulation under the current administration is still unclear. The FDA could introduce new regulatory hurdles that may not be welcomed by the industry, according to an article in Axios, published in October. Meanwhile, news reports in December suggest that the FDA may relax a warning label rule for supplements, according to NBC News.

If you’re reporting on the topic, it’s important to inform your audiences about the promises, limitations and potential harms of over-the-counter supplements.

Below, we’ve gathered credible sources of information, fact-checked data and peer-reviewed research studies to help you with your reporting. We address the following topics:

The questions are followed by two pieces of advice for journalists, five research studies about dietary supplements and more reporting resources.

What are dietary supplements?

The term “dietary supplement” was defined in the Dietary Supplement Health and Education Act of 1994 as “a product intended for ingestion that, among other requirements, contains a ‘dietary ingredient’ intended to supplement the diet.”

The term “dietary ingredient” includes:

  • Vitamins and minerals, such as multivitamins, individual vitamins, calcium, and iron.
  • Herbs and other botanicals, such as echinacea and ginger.
  • Amino acids, such as tryptophan and glutamine.
  • “Dietary substances” that are part of the food supply, such as enzymes and live microbials (commonly referred to as “probiotics”).
  • Concentrates, metabolite extracts, or combinations of any dietary ingredient from the categories listed above.

Dietary supplements may have two types of ingredients:

  • Dietary ingredients, listed above.
  • Other ingredients, such as fillers, binders, preservatives, sweeteners and flavorings.

Dietary supplements may be found in many forms, such as pills, tablets, capsules, gummies, softgels, liquids, powders, teas and bars. Topicals or inhaled products are not supplements.

What are some key supplement use statistics in the U.S.?

The use of dietary supplements has been on the rise in the U.S., increasing from 50% of adults and children in 2007 to 56% in 2018, according to a 2022 survey study published in the Journal of Nutrition.

A 2024 study analyzing data from the 2011 to 2018 National Health and Nutrition Examination Survey, including a total of 12,529 participants, found that more than 70% of the respondents took dietary supplements daily. Nearly 40% said they had been taking supplements for more than five years, and 67% said they were “highly adherent to at least one supplement.”

The U.S. dietary supplements market size was estimated at $64 billion in 2024 and is projected to reach $124 billion by 2033, according to a market analysis report by Grand View Research.

The global value of the dietary supplements market was estimated to be around $152 billion in 2021, and expected to grow to $300 billion by 2028, according to a 2023 study, “A Global Overview of Dietary Supplements: Regulation, Market Trends, Usage during the COVID-19 Pandemic, and Health Effects,” published in Nutrients.

How are supplements regulated and how are the regulations enforced?

The Dietary Supplement Health and Education Act of 1994 is the main legal framework that governs supplements today, shaping debates over consumer safety, misleading health claims and whether supplements should face stricter oversight similar to drugs. DSHEA classifies supplements as a category of food rather than drugs.

The act created a distinction based on whether an ingredient was on the market prior to its passage.

  • Dietary ingredients marketed in the U.S. before the passage of the act are presumed safe and do not require FDA safety review.
  • Ingredients introduced after the act’s passage are classified as New Dietary Ingredients. This means manufacturers must submit a notification to the FDA 75 days prior to marketing, providing information on why the ingredient is “reasonably expected to be safe.”

Unlike prescription drugs, dietary supplements are not evaluated by the FDA for safety or efficacy before arriving on the market. Manufacturers are not required to perform clinical trials. “In fact, in many cases, firms can lawfully introduce dietary supplements to the market without even notifying FDA,” according to the agency.

DSHEA created a post-market or reactive regulatory approach for the FDA, placing the burden of proof on the government to show that a product is unsafe, adulterated or misbranded before it can be removed from the market.

The legislation requires supplement manufacturers to notify the agency when they introduce a new dietary ingredient into the market. But in 2022, the FDA estimated that it had not been informed about at least 3,400 new ingredients in available supplements, according to a STAT+ article.

The FDA has several enforcement tools to remove hazardous ingredients from dietary supplements. They include issuing warning letters to manufacturers, requesting or mandating that manufacturers recall products, and publishing public notices, according to a 2022 study published in JAMA.

Still, as Cohen has found in his research, some products remain on the market for years after the FDA issues warning letters about them.

The FDA and the Federal Trade Commission share responsibility for the oversight of dietary supplements and related promotion. The FDA generally is responsible for safety, quality and labeling, and the FTC is responsible for regulating advertising. Both agencies have the authority to take enforcement actions against dietary supplements and firms in case of violations.

Globally, dietary supplements are also loosely regulated and there is little agreement between countries on the definitions or terminology used to classify the supplements and regulatory requirements, according to a 2023 study published in Nutrients.

What are the benefits and harms of taking supplements?

Certain vitamins can prevent diseases that are the result of vitamin deficiencies. For instance, vitamin C can prevent scurvy and vitamin D can prevent rickets. Patients who have undergone bariatric surgery may need supplements. Lack of folic acid in pregnant people has been associated with an increased risk of certain neurological defects in babies, according to a 2021 reporting resource by SciLine, which summarizes research findings about the benefits of long-term use of supplements and vitamins.

“On the other hand, there might be extracts of particular botanicals that have no proven benefit, that are sold right next to the vitamins,” Cohen says.

Supplements can also interfere with prescription medications. For example, herbal St. John’s wort, often used for mood disorders, may interfere with the effectiveness of certain medications such as antidepressants, blood thinners, birth control pills and some cancer treatments, according to a January 2025 article in the National Institutes of Health’s MedlinePlus Magazine.

The most serious safety issue of dietary supplements is the sale or marketing of products that are adulterated with illegal or unsafe ingredients whose efficacy hasn’t been shown.

In a 2021 study, Cohen and his co-authors found several unapproved drugs, including ones that were not approved for human use in the U.S., in over-the-counter supplements marketed to improve memory and cognitive function.

In another analysis, published in JAMA Network in 2023, Cohen and his co-authors found that the labels of 89% of performance-enhancing dietary supplements did not accurately declare the ingredients that were in the products, and 12% of products contained ingredients prohibited by the FDA.

The three most problematic dietary supplement categories in the U.S are sexual enhancement supplements, weight loss supplements, and sports performance and bodybuilding supplements, according to the 2023 study.

Are dietary supplement serving sizes standardized?

No. According to the FDA, “Other than the manufacturer’s responsibility to meet the safety standards and labeling requirements for dietary supplements and to comply with current good manufacturing regulations, there are no laws or regulations that limit the serving size of a dietary supplement or the amount of a dietary ingredient that can be in a serving of a dietary supplement. This decision is made by the manufacturer and does not require FDA approval.”

What do stamps on supplement labels really tell you?

There are a variety of quality and safety stamps on the labels of dietary supplements, and not all carry the same weight.

“Most of [the stamps] are not going to be very useful,” Cohen says.

In some cases, the supplement manufacturer has paid a company to give it a stamp of approval on its label, Cohen says.

“My recommendation is to go for the third-party programs that are very solid,” he said.

Here are two organizations that Cohen trusts:

  • U.S. Pharmacopeia is an independent, scientific nonprofit organization focused on building trust in the supply of safe and quality medicines.
  • NSF is an independent organization that plays a pivotal role in the development of robust public health standards.

Advice for journalists

Cohen offered the following advice to journalists when reporting on dietary supplements.

Report on the nuances of supplements.

Certain supplements are effective at a certain dose, similar to medications.

“Let’s take creatine, for example,” which can be used to slightly increase the ability to lift weight, Cohen says.

The supplement is sometimes portrayed in news stories and other content as either great or dangerous to health, but the reality is more nuanced.

“When it comes to things that have some evidence that they work, what’s often missed is the idea that the only way something’s going to work is if you’re taking an accurately labeled product at the proper dose that has been shown in studies to be effective,” Cohen says.

“Just like a prescription medication, you wouldn’t be like, ‘Oh, let’s take Lipitor at any dose’. We know that makes no sense,” Cohen says. “It’s the same thing for all the supplements. We just need to realize they’re just like medications and take them seriously, and that part of the story is often lost.”

Remind your audience that an FDA warning letter doesn’t mean the supplement will be removed from the market right away.

The FDA’s primary responsibility is to ensure the safety and purity of dietary supplements after they are marketed and to remove any product that may be potentially dangerous to consumers from the market, according to a 2023 study published in the journal Nutrients.

But researchers like Cohen, who study supplements, say that some products remain on the market for years after the FDA issued warning letters about them.

“The FDA has not been doing its job to even use the laws it does have to ensure the safety of supplements,” for the last several decades, Cohen says. “So people need to understand that the FDA has not, historically and will continue not to be, responsible in terms of doing its little part in trying to ensure a little bit of supplement safety.”

In a 2022 study, listed below, Cohen and his co-authors find that nine of the 31 products they analyzed remained available for purchase online for an average of 6 years after the FDA issued warning letters.

Five research studies to consider

Recalls, Availability, and Content of Dietary Supplements Following FDA Warning Letters
Pieter A Cohen, Bharathi Avula, Kumar Katragunta, and Ikhlas Khan. JAMA, July 2022.

  • This study investigates whether dietary supplements that received FDA warning letters for containing prohibited stimulants, such as amphetamine-like substances, were recalled, removed from the market, or became free of banned ingredients.
  • Researchers identified 31 supplements that had received FDA warning letters for the presence of three prohibited stimulants: amphetamine analogue β-methylphenethylamine (BMPEA), the ephedrine analogue methylsynephrine (Oxilofrine), or dimethylamylamine analogue octodrine (DMHA or octodrine). The FDA issued warning letters for these stimulants in 2015, 2016, and 2019, respectively, mandating that manufacturers inform the FDA of the steps the firm will take to correct the violation and prevent similar violations in the future.
  • Of these 31 products, one was recalled by the manufacturer. Nine of the 31 products — 29% — remained available for purchase online for an average of 6 years after the FDA issued warning letters.
  • The results may not be generalizable to all dietary supplements subject to FDA warning letters. It’s also not clear whether the presence of adulterants might vary from batch to batch or over time.

Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication
Elizabeth O’Connor, et al. U.S. Preventive Services Task Force, June 2022.

  • Across 84 studies with a total of 739,803 participants, the researchers found that common supplements, including vitamin D, vitamin E, calcium, vitamin C, B vitamins, magnesium, selenium and zinc, generally do not reduce the risk of cardiovascular disease, cancer or death.
  • Use of multivitamins was associated with a very small reduction in the overall risk of cancer and a small decrease in lung cancer.
  • Consuming beta carotene supplements increases the risk of lung cancer, especially among smokers or in people exposed to asbestos. It also increased the risk of cardiovascular death.
  • Use of other vitamins also carries risk. For instance, the use of vitamin E was associated with an increased risk of hemorrhagic stroke. Use of 1,000 units or more of vitamin D was associated with an increased risk of kidney stones.

Dietary Supplements — For Whom? The Current State of Knowledge about the Health Effects of Selected Supplement Use
Regina Ewa Wierzejska. International Journal of Environmental Research and Public Health, August 2021.

  • The goal of this scoping review is to present what is known about the effects of using selected dietary supplements for chronic diseases and the risks associated with their use.
  • The author’s review of literature shows that vitamin and mineral supplements neither lower the risk of cardiovascular diseases nor prevent the development of cancers in healthy people.
  • Most of the randomized controlled trials analyzed in this review found that vitamin and mineral supplements do not lower the risk of cardiovascular diseases and cancer.
  • For weight loss supplements, the use either has a marginal benefit or is completely ineffective. Meanwhile, their side effects and the risk of contamination with illegal substances remain concerning.

Label Statements and Perceived Health Benefits of Dietary Supplements
Joanna Nicole Assadourian, Eric D. Peterson, and Ann Marie Navar. JAMA Network Open, September 2025.

  • Researchers conducted two online surveys of U.S. adults, one for a fish oil supplement (2,239 participants) and one for a fictional supplement called Viadin H (2,164 participants).
  • For each survey, participants were randomized to one of four labels that were otherwise identical but had different health-related statements on the label. The surveys were conducted between January and March 2024.
  • Participants exposed to claims that included heart-related words, or brain health or cognitive function wording on labels, were more likely to believe the supplement did what they claimed, even for the fictional supplement.
  • The results show that consumers often interpret vague label statements as implying disease prevention or treatment benefits, even though such wording is not intended to imply specific effects on disease prevention under FDA rules.

A Global Overview of Dietary Supplements: Regulation, Market Trends, Usage during the COVID-19 Pandemic, and Health Effects
Ouarda Djaoudene, et al. Nutrients, July 2023.

  • This overview provides a global comparison of supplement regulation and cross-border sales.
  • The authors provide market numbers, growth trends and usage statistics.
  • In addition, the study examines how the COVID-19 pandemic affected supplement use globally.

Additional resources

This <a target=”_blank” href=”https://journalistsresource.org/home/dietary-supplements-key-facts-research-studies-and-advice-for-journalists/”>article</a> first appeared on <a target=”_blank” href=”https://journalistsresource.org”>The Journalist’s Resource</a> and is republished here under a <a target=”_blank” href=”https://creativecommons.org/licenses/by-nd/4.0/”>Creative Commons Attribution-NoDerivatives 4.0 International License</a>.<img src=”https://journalistsresource.org/wp-content/uploads/2020/11/cropped-jr-favicon-150×150.png” style=”width:1em;height:1em;margin-left:10px;”>



Source link

22 12, 2025

XRP Holds Near $1.94 as Spot ETF Inflows Meet a Tough $2 Wall

By |2025-12-22T22:49:42+02:00December 22, 2025|Crypto News, News|0 Comments

Updated: December 22, 2025, 1:41 p.m. ET (18:41 UTC)

XRP is trading around $1.94 at roughly 1:41 p.m. ET on December 22, 2025, as buyers try (again) to regain the psychologically important $2.00 level. In today’s session, XRP has ranged roughly between $1.91 and $1.94, reflecting a market that’s stabilizing—but still struggling to spark a decisive breakout.

Despite the sideways price action, activity remains heavy: CoinMarketCap lists XRP’s 24-hour trading volume at about $2.29 billion, with XRP up about 1.4% over the past 24 hours and holding the #5 spot by market cap (around $116.95 billion). [1]

What’s driving XRP today

The big theme on December 22, 2025 is a tug-of-war:

  • Tailwind: continued inflows into XRP-related products (especially spot ETFs), which suggest sustained institutional demand.
  • Headwind: persistent technical resistance overhead—especially around $1.98–$2.00 and above—plus broader risk sensitivity tied to U.S. regulation and macro expectations.

Several analysts note that XRP has held above $1.90 support but repeatedly failed to clear $2.00, leaving price stuck in a tight band where every rally attempt meets sellers. [2]

XRP price recap for December 22, 2025

Here’s the “where we are” snapshot as of early afternoon U.S. hours:

  • Price: ~$1.94
  • Intraday range (so far): ~$1.91–$1.94
  • Market tone: mild rebound, but still “range-bound” under $2

[3]

For a broader daily view, Investing.com’s daily data for Dec. 22 shows XRP trading around $1.93, with an approximate high near $1.95 and low near $1.91 (figures vary slightly by venue/index methodology). [4]

The ETF story: inflows continue, but price still can’t clear $2

One of the most important XRP narratives today is that money is still flowing in—even while price stalls.

U.S. spot XRP ETF flow highlights (latest reporting week)

Analysts tracking SoSoValue-reported flows say:

  • Weekly net inflows: about $82.04 million (week ending Dec. 19)
  • Daily net inflow: about $13.21 million on Dec. 19
  • Cumulative net inflows: about $1.07 billion
  • Total net assets: about $1.21 billion

These figures are widely cited across multiple market updates today, with the nuance that the latest week’s inflow pace was described as the weakest since launch—still positive, but not accelerating the way bulls would like. [5]

So why isn’t XRP ripping higher?

Two explanations show up repeatedly in today’s analysis:

  1. Technical overhead is heavy. FXStreet notes XRP remains below key moving averages (including the 50-day EMA around $2.13) even as price holds above $1.90—often a recipe for choppy “two steps forward, one step back” trading. [6]
  2. Spot price can lag flows. Some market commentators argue ETF-style demand can be absorbed without instantly translating into a spot breakout—especially if profit-taking, hedging, and large-holder repositioning are happening in parallel. [7]

Bigger-picture crypto funds: CoinShares flags risk-off, but XRP stands out

Beyond XRP-specific ETFs, the broader digital-asset fund backdrop turned risk-off this week.

CoinShares’ weekly fund flows report (published today) says digital-asset investment products saw about $952 million in outflows, attributing the move to delays in the U.S. “Clarity Act” and concerns over whale selling. Outflows were concentrated mostly in U.S.-based products (~$990M), led by Ethereum (~$555M) and Bitcoin (~$460M). [8]

In that same CoinShares data, XRP-linked products bucked the trend, drawing roughly $62.9 million of inflows (with Solana also positive). That contrast—broad outflows while XRP demand stays positive—is a big reason XRP keeps showing up on “watchlists” today even without a clean price breakout. [9]

Technical analysis: key XRP levels traders are watching today

Across the day’s technical notes, a few price zones repeat.

Resistance levels

  • $1.98: a key “reclaim” area highlighted as a volume/structure level by crypto.news (often framed as the hurdle needed to open a move toward $2.20). [10]
  • $2.00: the psychological pivot; repeated failures here are a major theme in both technical and narrative coverage today. [11]
  • $2.13 / $2.31 / $2.41: FXStreet flags these as the 50/100/200-day EMA zones above price—levels that can attract sellers until decisively reclaimed. [12]

Support levels

  • $1.90: the near-term floor that XRP has defended recently. [13]
  • $1.77: flagged as a critical downside level; FXStreet points to it as a support zone, and a CoinDesk technical note warns that losing $1.77 could expose far lower supports (with ~$0.80 referenced as a major level in that scenario). [14]
  • $1.61: cited by FXStreet as a deeper downside level (not a base case, but a level traders keep on maps when volatility returns). [15]

Indicators and signals (mixed)

FXStreet describes XRP’s RSI around 42 (suggesting weak-to-neutral momentum) while also noting a MACD buy signal on the daily chart—an example of why today’s outlook is often framed as “cautiously constructive, but not confirmed.” [16]

Meanwhile, U.Today’s intraday read puts local resistance around $1.9493, suggesting that if bulls keep control, a push into $1.97–$1.98 is plausible—again pointing back to that crucial pre-$2 zone. [17]

Pattern watch: “bottoming” signals vs. bearish structure

Today’s market commentary isn’t one-sided. It splits into two camps: early bottoming signals and still-bearish structure.

The “possible bottom” case

Crypto.news highlights a swing failure pattern (SFP) around $1.80, a formation often interpreted as sellers exhausting momentum. In that view, the market needs to reclaim $1.98 to confirm strength, which could open a path toward $2.20. [18]

AMBCrypto adds a sentiment angle, saying XRP has slipped into Santiment’s “fear zone,” a condition they argue has historically coincided with local bottoms. They also point to stabilization behavior around the $1.83–$1.87 area in recent price action. [19]

The “trend is still bearish” case

Other coverage stresses that XRP is still trading below multiple EMAs, meaning rallies can remain corrective until price breaks and holds above major resistance. [20]

Forecasts for XRP from December 22, 2025: what analysts and models expect next

Forecasting crypto is inherently uncertain, but here’s what today’s most-cited outlooks imply—grouped by time horizon.

Short-term (days to ~2 weeks): $1.90–$2.00 remains the battlefield

  • FXStreet frames XRP as stable above $1.90, but still needing a clean break over $2.00 to confirm a stronger recovery. [21]
  • Multiple intraday reads converge on $1.97–$1.98 as the “next test” if momentum holds. [22]

Medium-term (4–12 weeks): bullish targets depend on a $2 breakout

FXEmpire’s analysis suggests a break above $2 could open the path toward $2.5 and $3.0 targets over the coming weeks, while also emphasizing that ETF inflow momentum has cooled versus earlier weeks. [23]

Model-based projections: mostly flat near-term

Binance’s XRP price-prediction page (a model/tool-style forecast) shows XRP projected around the $1.93–$1.94 area for late December dates—essentially calling for a modest, low-volatility drift unless a catalyst breaks the range. [24]

Longer-term “blue-sky” scenario: the $10 debate resurfaces

The Motley Fool revisits the question of whether XRP could reach $10 in 2026, arguing it would require conditions like strong ETF demand and/or structural buying waves similar to prior explosive runs. It’s a speculative scenario—but it’s part of the bullish narrative circulating today. [25]

What to watch next: the catalysts that could finally move XRP

If you’re tracking XRP into year-end, today’s coverage suggests focusing on a few “market-moving” categories:

  1. Daily/weekly ETF flow prints (are inflows accelerating again—or fading further?). [26]
  2. U.S. regulatory headlines, especially anything tied to the Clarity Act timeline and broader market-structure progress (a key driver behind this week’s risk-off move in crypto funds). [27]
  3. The $1.98–$2.00 technical gate—break and hold above it, and upside targets expand; lose key supports like $1.77, and downside scenarios quickly get louder. [28]
  4. Derivatives positioning and liquidity (open interest and funding dynamics), which FXStreet notes have shown signs of renewed retail participation. [29]

Bottom line

As of 1:41 p.m. ET on December 22, 2025, XRP is hovering near $1.94, with strong trading activity and steady inflows into XRP-linked products—but still trapped beneath the market’s most important near-term ceiling at $2.00. [30]

The market’s message today is consistent: flows are supportive, sentiment is tense, and the chart needs confirmation. If XRP can reclaim $1.98–$2.00 and then tackle higher EMA resistance, forecasts expand quickly. If not, traders remain focused on defending $1.90 and avoiding a breakdown toward $1.77 and below. [31]

References

1. coinmarketcap.com, 2. www.fxstreet.com, 3. coinmarketcap.com, 4. www.investing.com, 5. www.fxempire.com, 6. www.fxstreet.com, 7. www.fxempire.com, 8. researchblog.coinshares.com, 9. researchblog.coinshares.com, 10. crypto.news, 11. www.fxstreet.com, 12. www.fxstreet.com, 13. www.fxstreet.com, 14. www.fxstreet.com, 15. www.fxstreet.com, 16. www.fxstreet.com, 17. u.today, 18. crypto.news, 19. ambcrypto.com, 20. www.fxstreet.com, 21. www.fxstreet.com, 22. crypto.news, 23. www.fxempire.com, 24. www.binance.com, 25. www.fool.com, 26. www.fxempire.com, 27. decrypt.co, 28. www.fxstreet.com, 29. www.fxstreet.com, 30. coinmarketcap.com, 31. www.fxstreet.com

Source link

22 12, 2025

NEXUS and CertiK Team Up to Strengthen Web3 Gaming Security

By |2025-12-22T21:42:35+02:00December 22, 2025|News, NFT News|0 Comments


NEXUS Co., Ltd, a company listed on South Korea’s KOSDAQ market and the developer of the CROSS blockchain gaming platform, has entered into a memorandum of understanding with CertiK, a globally recognized blockchain security firm. The collaboration reflects a growing emphasis on trust, security, and regulatory readiness as Web3 gaming platforms aim to reach mainstream audiences.

The agreement was announced on December 22, 2025, at a time when the CROSS ecosystem was undergoing active expansion. The timing underscores the increasing importance of robust security frameworks and compliance measures for blockchain-based gaming and payment solutions. The MOU was signed by NEXUS Chief Executive Officer Henry Chang and CertiK Co-founder and Chief Executive Officer Ronghui Gu, marking the beginning of a long-term strategic relationship between the two organizations.

NEXUS oversees the core infrastructure of the CROSS platform, including blockchain-based gaming services, a decentralized exchange, digital wallets, and creator-focused tools. The partnership arrives as the company prepares to introduce stablecoin-enabled payment systems designed to simplify in-game and service-related transactions. These developments make security and compliance critical priorities for the platform’s next phase of growth.

CertiK’s Security Expertise Supports Platform Expansion

CertiK has built a strong reputation in the Web3 sector for its smart contract audits, real-time risk detection, and continuous on-chain monitoring services. The firm has assessed more than 5,000 blockchain projects and plays a role in safeguarding digital assets valued at approximately $600 billion. Its client base includes major industry players such as Ethereum, Binance, and Tether, highlighting its influence and credibility within the blockchain ecosystem.

The partnership aligns with NEXUS’s strategy of embedding security into the platform from the earliest stages of development. As CROSS scales through the use of software development kits, application programming interfaces, wallets, and digital marketplaces, comprehensive protection is essential to prevent vulnerabilities. This need becomes even more pronounced with the introduction of stablecoins, where secure settlement and payment reliability are vital for user confidence.

Four Core Areas of Collaboration

Under the MOU, the partnership is structured around four primary pillars. The first focuses on security and smart contract auditing, with CertiK conducting in-depth reviews of CROSS components related to gaming, payments, and stablecoin contracts to ensure transparency and scalability.

The second area involves live on-chain risk monitoring. This includes continuous oversight of blockchain activity and smart contracts, along with the sharing of security intelligence to identify and mitigate threats before they escalate.

The third pillar addresses compliance and stablecoin frameworks tailored to Asian markets. This aspect emphasizes regulatory checks and best practices that align with global standards for gaming payments and cross-border transactions.

The final area centers on business development and regional expansion. Both companies plan to collaborate on market strategies, ecosystem growth initiatives, and partner engagement across Asia. CertiK is also evaluating the possibility of a strategic investment in NEXUS to further reinforce the long-term partnership.

Strengthening the CROSS Ecosystem

CROSS is supported by a team of more than 100 professionals specializing in blockchain technology and gaming. Through this partnership, the platform is expected to enhance payment security, strengthen user trust, and improve compliance across its ecosystem. As Web3 gaming continues to evolve, such measures are becoming essential for sustainable growth and broader adoption.

NEXUS leadership has indicated that the collaboration represents a significant milestone, enabling the company to adopt global-grade security standards while accelerating infrastructure and business expansion. The firm has emphasized its commitment to building systems that combine innovation with resilience and transparency to support long-term growth.

From CertiK’s perspective, the partnership reflects the rising need for strong governance, compliance, and security as stablecoins and on-chain gaming gain traction. The company views its work with NEXUS as a meaningful step toward raising security standards across the Web3 industry and supporting the ecosystem’s continued innovation and maturity.





Source link

22 12, 2025

Gold (XAUUSD) Price Forecast: Gold Rally Accelerates After $4381.44 Breakout

By |2025-12-22T21:39:35+02:00December 22, 2025|Forex News, News|0 Comments


At 11:14 GMT, XAUUSD is trading $4408.58, up $69.81 or +1.61%.

Upside Momentum Dominates Gold Market Positioning

Gold’s advance shows conviction rather than late-stage exhaustion. The metal is now up nearly 70% year-to-date, marking its strongest annual performance since 1979. Central bank accumulation, sustained portfolio hedging, and persistent geopolitical risk continue to absorb supply, keeping pauses brief and shallow.

The former resistance at $4381.44 has been decisively cleared. What capped price last week is now accepted above, reinforcing confidence that higher levels are being built on participation, not thin volume spikes.

Gold Buyers Ignore Higher Yields As Conviction Builds

A key signal today is gold’s resilience in the face of rising Treasury yields. The U.S. 10-year yield is ticking higher, yet gold shows no sensitivity. When gold rallies alongside firmer yields, it typically reflects urgency to secure exposure rather than rate-driven positioning, reinforcing the strength of current demand.

This behavior suggests positioning is being driven by capital preservation and risk hedging rather than tactical rate trades.

Rates, Policy Expectations, And Real Asset Demand Support Gold

Expectations for lower U.S. interest rates remain a core tailwind. Federal Reserve Governor Stephen Miran reiterated that easing inflation supports rate cuts to offset labor market risks. Gold continues to benefit from lower real-rate expectations even as nominal yields firm.



Source link

22 12, 2025

5 Supplements To Avoid if You Have High Blood Pressure

By |2025-12-22T20:54:40+02:00December 22, 2025|Dietary Supplements News, News|0 Comments


Managing hypertension (high blood pressure) is necessary to lower your risk of other health conditions, like heart attack or stroke. To best manage high blood pressure, you may need to avoid certain supplements because they can affect your blood pressure or make your blood pressure medication less effective.

Vitamin D is a vitamin naturally found in certain foods and available as a supplement. Your body also makes vitamin D when your skin is exposed to ultraviolet (UV) rays from the sun. Vitamin D is necessary for many body functions, like bone health and inflammation.

Some researchers have found that vitamin D may help treat high blood pressure, specifically doses of 200-8,000 International Units (IU) per day. Doses of vitamin D larger than 10,000 IU per day can lead to dangerous side effects, like high levels of calcium (hypercalcemia). Hypercalcemia can cause many issues over time, including high blood pressure.

High doses of vitamin D can also interact with certain diuretics (water pills) used to treat high blood pressure. This interaction can cause your body to not get rid of enough calcium, raising your calcium levels and possibly raising your blood pressure.

Talk to your primary care provider about your vitamin D levels. They can test your levels to determine if vitamin D supplementation would be useful for you and your blood pressure.

Licorice root (Glycyrrhiza glabra) is an herb used as a flavoring in food, candy, and tobacco products. In traditional medicine, the root has been used to treat lung disease, liver disease, and wounds.

Licorice contains glycyrrhizic acid (GA), an ingredient that can raise blood pressure and cause serious side effects if you have high blood pressure. GA doses as low as 100 milligrams daily have been shown to raise blood pressure.

Supplements with GA can also interact with diuretics and blood pressure medications. The supplement may affect how well blood pressure medication works and raise your risk of side effects. Specifically, licorice root can raise sodium levels and lower potassium levels in your body. This effect, combined with a diuretic, can lead to dangerously low levels of potassium.

If you have high blood pressure, it’s best to avoid using products with licorice root.

St. John’s wort (Hypericum perforatum) is a plant used to treat symptoms of depression and menopause. Despite its historical use as a traditional medicine, the plant may dangerously interact with a variety of medications. St. John’s wort weakens the effects of many medications, including some used to treat high blood pressure.

Examples of blood pressure medications that interact with St. John’s wort include:

  • Procardia (nifedipine)
  • Talinolol
  • Verelan (verapamil)

These interactions likely occur because St. John’s wort blocks the medication from being absorbed in the body as it normally would.

Talk with your healthcare provider before taking St. John’s wort. They can tell you if the supplement may interact with any other medications or supplements you are taking.

Arnica is a flower in the sunflower family. The flower has been used to help with bruising, inflammation, and swelling when applied directly to the skin.

Experts recommend against taking arnica by mouth due to a risk for significant side effects. These side effects may include high blood pressure, increased bleeding, vomiting, diarrhea, and damage to your heart or other organs.

Bitter orange (Citrus aurantium) is taken from the fruit or peel of a bitter orange. The fruit and its peel can be used to add flavor to drinks or aromas to perfumes. The bitter orange supplement is often used to help with weight loss and improve sports performance.

Bitter orange contains p-Synephrine, a type of stimulant similar to ephedrine. The U.S. Food and Drug Administration (FDA) has banned ephedrine stimulants because they can cause health issues like stroke and heart attack. Though bitter orange is not banned, it should be used with extreme caution.

Studies have shown that bitter orange supplements can raise blood pressure and heart rate. The supplement can also raise your risk for other serious side effects like stroke and heart attack. However, bitter orange found in food and drinks is not likely to affect your blood pressure or cause these side effects.

Talk with your healthcare provider before taking bitter orange.

People may respond to certain supplements differently. Factors that may affect how you respond to a supplement include genetics, diet and nutrition, age, gut health, and overall health status. Take note of any side effects or symptoms you experience when starting a new supplement or vitamin.

Before starting any new vitamins or supplements, talk to your doctor. They can help you decide if the vitamin or supplement would be useful and safe for you to take. Your doctor can also compare the new supplement to all the medications, vitamins, and other supplements you already take to identify potential interactions.



Source link

Go to Top